• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reporting adverse drug events to the Therapeutic Goods Administration.向治疗用品管理局报告药品不良反应事件。
Aust Prescr. 2021 Feb;44(1):2-3. doi: 10.18773/austprescr.2020.077. Epub 2021 Feb 1.
2
Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.医务人员在巴格达市报告药物不良反应的经验：横断面研究。
Int J Clin Pharm. 2019 Oct;41(5):1307-1313. doi: 10.1007/s11096-019-00867-7. Epub 2019 Jun 25.
3
Annual report: surveillance of adverse events following immunisation in Australia, 2009.年度报告：2009年澳大利亚免疫接种后不良事件监测
Commun Dis Intell Q Rep. 2010 Sep;34(3):259-76.
4
Effect of the black triangle scheme and its online educational campaign on the quantity and quality of adverse drug event reporting in Australia: a time series analysis.黑色三角计划及其在线教育活动对澳大利亚药物不良事件报告数量和质量的影响：一项时间序列分析
Expert Opin Drug Saf. 2020 Jun;19(6):747-753. doi: 10.1080/14740338.2020.1746762. Epub 2020 Mar 31.
5
Allergic reactions to Japanese encephalitis vaccine.对日本脑炎疫苗的过敏反应。
Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. doi: 10.1016/s0889-8561(03)00102-4.
6
Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.药物相关性急性肾损伤在美国食品和药物管理局不良事件报告系统数据库中的识别。
Pharmacotherapy. 2018 Aug;38(8):785-793. doi: 10.1002/phar.2152. Epub 2018 Jul 13.
7
Surveillance of adverse events following immunisation in Australia annual report, 2016.《2016年澳大利亚免疫接种后不良事件监测年度报告》
Commun Dis Intell (2018). 2018;42. Epub 2018 Nov 16.
8
A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.患者视角：药物不良反应对患者的影响及其对报告的看法。
J Clin Pharm Ther. 2012 Apr;37(2):148-52. doi: 10.1111/j.1365-2710.2011.01258.x. Epub 2011 May 18.
9
Improving the reporting of adverse drug reactions in the hospital setting.改善医院环境中的药物不良反应报告。
Postgrad Med. 2010 Nov;122(6):154-64. doi: 10.3810/pgm.2010.11.2233.
10
Adverse Drug Event Reporting Rates After the Implementation of an EHR Integrated Reporting System.电子健康记录集成报告系统实施后的药品不良事件报告率
Stud Health Technol Inform. 2019 Aug 21;264:1652-1653. doi: 10.3233/SHTI190580.

引用本文的文献

1
Strengthening Dental Materiovigilance: A Review of International Reporting Frameworks.加强牙科药物警戒：国际报告框架综述
Int Dent J. 2025 Aug 6;75(5):100943. doi: 10.1016/j.identj.2025.100943.
2
Exploring Complementary Medicine Usage, Consumer Perceptions, and Impact of Label Warnings: A Cross-Sectional Study in Melbourne, Australia.探索辅助医学的使用情况、消费者认知以及标签警示的影响：澳大利亚墨尔本的一项横断面研究。
Pharmacy (Basel). 2025 Apr 27;13(3):61. doi: 10.3390/pharmacy13030061.
3
Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project).共同设计以消费者为中心的数字健康报告平台以改善药品不良事件报告：多方法研究项目（ReMedi项目）方案
JMIR Res Protoc. 2025 Jan 15;14:e60084. doi: 10.2196/60084.
4
Consumers' knowledge and experiences of adverse drug reaction reporting in Australia: a national survey.消费者对澳大利亚药物不良反应报告的了解和经验：一项全国性调查。
Eur J Clin Pharmacol. 2024 Oct;80(10):1543-1554. doi: 10.1007/s00228-024-03729-y. Epub 2024 Jul 12.
5
TGA and -back to the future (take 2).完全性大动脉转位与——回到未来（第二幕）。
Aust Prescr. 2024 Feb;47(1):29. doi: 10.18773/austprescr.2024.003.
6
Limitations of randomised controlled trials as evidence of drug safety.随机对照试验作为药物安全性证据的局限性。
Aust Prescr. 2023 Aug;46(2):22-23. doi: 10.18773/austprescr.2023.005.
7
Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories.澳大利亚直接全科医生报告药物不良反应的持续下降和澳大利亚安全建议报告中细节的缺乏。
Drug Saf. 2023 Jul;46(7):703-710. doi: 10.1007/s40264-023-01321-4. Epub 2023 Jun 2.
8
Consumer-Generated Discourse on Cannabis as a Medicine: Scoping Review of Techniques.消费者生成的关于大麻作为药物的论述：技术范围综述。
J Med Internet Res. 2022 Nov 16;24(11):e35974. doi: 10.2196/35974.
9
Vaccine safety: what systems are required to ensure public confidence in vaccines?疫苗安全：需要哪些系统来确保公众对疫苗的信心？
Med J Aust. 2022 Aug 15;217(4):189-190. doi: 10.5694/mja2.51662. Epub 2022 Jul 17.
10
NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes.新南威尔士州大麻药物咨询服务初步调查结果：咨询者看法和患者结果。
Intern Med J. 2022 Feb;52(2):228-237. doi: 10.1111/imj.15635. Epub 2022 Feb 10.

本文引用的文献

1
Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed model.欧洲监管科学与创新计划（ReScIPE）：一种拟议模式。
Br J Clin Pharmacol. 2020 Dec;86(12):2530-2534. doi: 10.1111/bcp.14099. Epub 2019 Oct 17.
2
Defining and classifying terminology for medication harm: a call for consensus.定义和分类用药危害的术语：呼吁达成共识。
Eur J Clin Pharmacol. 2019 Feb;75(2):137-145. doi: 10.1007/s00228-018-2567-5. Epub 2018 Oct 11.
3
Pharmacovigilance and expedited drug approvals.药物警戒与加速药物审批
Aust Prescr. 2018 Apr;41(2):50-53. doi: 10.18773/austprescr.2018.010. Epub 2018 Apr 3.
4
Improving reporting of adverse drug reactions: Systematic review.改进药物不良反应报告：系统评价。
Clin Epidemiol. 2009 Aug 9;1:75-92. doi: 10.2147/clep.s4775.
5
Widespread hyoscine hydrobromide toxicity due to contract manufacturer malpractice : the travacalm episode.因合同制造商违规操作导致的广泛的氢溴酸东莨菪碱中毒事件：曲美托嗪事件
Drug Saf. 2007;30(5):375-8. doi: 10.2165/00002018-200730050-00002.
6
Under-reporting of adverse drug reactions : a systematic review.药品不良反应报告不足：一项系统评价
Drug Saf. 2006;29(5):385-96. doi: 10.2165/00002018-200629050-00003.
7
Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.医院药品不良反应自发报告的障碍与解决办法
Br J Clin Pharmacol. 2005 Dec;60(6):653-8. doi: 10.1111/j.1365-2125.2005.02504.x.
8
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.

Reporting adverse drug events to the Therapeutic Goods Administration.

作者信息

Martin Jennifer H, Lucas Catherine

机构信息

Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, New South Wales.

Hunter New England Health, Newcastle, New South Wales.

出版信息

Aust Prescr. 2021 Feb;44(1):2-3. doi: 10.18773/austprescr.2020.077. Epub 2021 Feb 1.

DOI:10.18773/austprescr.2020.077
PMID:33664539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7900275/
Abstract
摘要